Form 4: Applied Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Leslie D. Funtleyder, Interim CEO and CFO of Applied Therapeutics, sold shares to cover tax withholding obligations related to vesting of restricted stock units.
Summary
- On February 6, 2025, Leslie D. Funtleyder, Interim CEO and CFO of Applied Therapeutics, sold 22,950 shares of common stock at a price of $0.61 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
- Following the transaction, Funtleyder directly owns 404,961 shares of Applied Therapeutics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's overall confidence in the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a lack of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Date of transaction: Sale of common stock. |
| 02/07/2025 | Date of signature on Form 4. |
Keywords
Form 4, Applied Therapeutics, APLT, Funtleyder, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.